News

In order to expand the potential uses of the drug against SARS-CoV-2, Gilead Sciences has announced plans to explore administration of remdesivir in an inhaled form.

Finch Therapeutics announced its investigational oral microbiome drug, CP101, reached a sustained clinical cure in its Phase 2 trial.

Data were published using the International Symposium on Pneumococci and Pneumococcal Diseases online digital library.

A video summary of the latest infectious disease headlines.

Company’s anti-infective agent sees setback related to COVID-19.

With the current COVID-19 outbreak, new data about Influenza mortality related to spectator sports should make the professional leagues and fans pause about attending games.

Compared to 2019, out-of-hospitalization cardiac arrest resuscitations saw a dramatic increase as well as differences in the types of patients experiencing these episodes.

Broad-spectrum antimicrobial therapy is common among critically ill patients, but few undergo antimicrobial de-escalation, a new study found.

Findings reveal that most unhealthy seniors and/or their families opt for comfort-directed care rather than life-sustaining treatment.

An overview of FDA drug pipeline news from the past week.

The week's FDA recall updates.

A June 19, 2020 recap of the biggest headlines in pandemic research and response.

A telephone survey confirms people are dealing with these issues and suggests it may be an early bellwether to providers and patients alike.

Although routinely prescribed after surgery, a new meta-analysis of studies on antibiotics and surgery finds there is no need for post-surgery antibiotics if best practices are followed.

In a recent US survey, African American male participants knew more people infected with COVID-19, had greater knowledge disparities, and were exposed to the virus more than other groups.

Health officials are urging parents to adhere to recommended vaccination schedules amid the COVID-19 pandemic, which has led to a drop in vaccination coverage.

A video review of the latest ID news.

Pregnant women with COVID-19 typically experienced symptoms in their second and third trimester, a new study shows.

Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.

the company announced it COVID-19 medication is looking to address viral replication and uncontrolled inflammatory response.

In a new analysis of Guangzhou city contact tracing data, investigators examined secondary attack rates of SARS-CoV-2.

An overview of 3 recent infectious disease news stories.

A modeling study from the UK reinforces how the transmission rates from infected people can be lowered using a variety of well-known strategies.

Providing oral antibiotics to people who inject drugs with infections may reduce hospital readmissions.

Vibeke Strand, MD, MACR, FACP, discusses patients who are having a hard time getting their usual supplies of HCQ.

A new phase 2b trial shows promise in HCV treatment.

Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.

Some countries have been proactive in patient logging and tracking. How can even retroactive assessment benefit future preventive responses?